1. 
Ding J, Jing X, Wang Y,
et al.
Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol,71(12)(2016),
pp.
1270-1276
2.
Hai-Tao Zhang,
Xin-Yi Gao,
Qin-Sha Xu,
et al.
Evaluation of the characteristics of hepatic
focal nodular hyperplasia: correlation between dynamic contrast-enhanced multislice computed tomography and pathological findings.
Onco Targets and Ther,
9 (2016),
pp.
5217-5224
3.Virgilio E, Cavallini M.
Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-invasive Approaches? A Review of the Preferable Treatment Options. Anticancer Res,38(1) (2018),
pp.
33-36
4.
Roux M,
Pigneur F,
Calderaro J,
et al. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
J Magn Reson Imaging,
42(5) (2015),
pp.
1249-1258
5.
Dohan A,
Soyer P,
Guerrache Y,
et a1. Focal nodular hyperplasia of the liver: diffusion weighted magnetic resonance imaging characteristics using high b values[J].
J Comput Assist Tomogr,
38(1) (2014),
pp.
96-104
6.Bartolotta TV1,
Taibbi A,
Brancatelli G,
et al. Imaging findings of hepatic focal nodular hyperplasia in men and women: are they really different? Radiol Med,
119(4) (2014),
pp.
222-30
7. Suh CH, Kim KW, Kim GY,
et al.
The diagnostic value of Gd - EOB - DTPA- MRI for the diagnosis of focalnodularhyperplasia: a systematic review and meta - analysis.
Eur Radiol,
25(4) (2015),
pp.
950-60
8.Sonja Kinner,Scott B.
Reeder,Takeshi Yokoo.
Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci,
61(5) (2016),
pp.
1337-1347
9.Lee CS, Jung YJ, KimSS,
et al. Liver volume - based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.
PLoS One,
13(1) (2018),
pp.
e0190261
10. Lee HW, Ahn SH.
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.
World J Gastroenterol,
22(37) (2016),
pp.
8314-8321
11.Chandrasegaram MD, Shah A, Chen JW,
et al.
Oestrogen hormone receptors in focal nodular hyperplasia. HPB (Oxford),17(6) (2015),
pp.
502-7
12.Lam A, Fernando D, Sirlin CC,
et al.
Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation. Clin Radiol,72(11) (2017),
pp.
994.e9-994
13.Ayuso C, Rimola J, Vilana R, et al.
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol,101(2018),
pp. 72-81
14.Peng Z, Li C, Chan T,
et al.Quantitative evaluation of Gd-EOB-DTPA uptake infocal liver lesions by using T1 mapping: differences betweenhepatocellularcarcino- ma, hepatic focal nodular hyperplasia and cavernous hemangioma. Oncotarget,8(39) (2017),
pp.
65435-65444
15. Luo M1, Zhang L, Jiang XH,
et al.Intravoxel incoherent motion: application indifferentiation of hepatocellular carcinoma and focal nodular hyperplasia Diagn Interv Radiol, 23(4) (2017),
pp.
263-271
16.Kitao A, Matsui O, Yoneda N,
et al. Differentiation Between HepatocellularCarcinomaShowing Hyperintensity on the HepatobiliaryPhase of GadoxeticAcid-EnhancedMRI and Focal Nodular Hyperplasia by CT and MRI.AJR Am J Roentgenol,211(2) (2018),
pp.
347-357
17. Gao SY, Tang L, Cui Y,et al.
Tumor angiogenesis-related parameters inmulti-phaseenhanced CT correlated with outcomes of hepatocellular carcinoma patientsafterradical hepatectomy. Eur J Surg Oncol,42(4) (2016),
pp.
538-544
18. Kim JE, Kim HO, Bae K, et al.
Differentiation of small intrahepatic mass-formingcholangiocarcinoma from small liver abscessby dual sourcedual-energyCTquantita-tive parameters. Eur J Radiol,92(2017),
pp.
145-152
19. Sano S, Yamamoto Y, Sugiura T,
et al.
The Radiological Differentiation ofHypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT. Anticancer Res, 38(9) (2018),
pp.5505-5512
